These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 33181138)
1. RAD6B Loss Disrupts Expression of Melanoma Phenotype in Part by Inhibiting WNT/β-Catenin Signaling. Sarma A; Gajan A; Kim S; Gurdziel K; Mao G; Nangia-Makker P; Shekhar MPV Am J Pathol; 2021 Feb; 191(2):368-384. PubMed ID: 33181138 [TBL] [Abstract][Full Text] [Related]
2. Alternative Splicing of RAD6B and Not RAD6A is Selectively Increased in Melanoma: Identification and Functional Characterization. Gajan A; Martin CE; Kim S; Joshi M; Michelhaugh SK; Sloma I; Mittal S; Firestine S; Shekhar MPV Cells; 2019 Nov; 8(11):. PubMed ID: 31683936 [TBL] [Abstract][Full Text] [Related]
4. Rad6B acts downstream of Wnt signaling to stabilize β-catenin: Implications for a novel Wnt/β-catenin target. Gerard B; Tait L; Nangia-Makker P; Shekhar MP J Mol Signal; 2011 Jul; 6():6. PubMed ID: 21767405 [TBL] [Abstract][Full Text] [Related]
5. Rad6B is a positive regulator of beta-catenin stabilization. Shekhar MP; Gerard B; Pauley RJ; Williams BO; Tait L Cancer Res; 2008 Mar; 68(6):1741-50. PubMed ID: 18339854 [TBL] [Abstract][Full Text] [Related]
6. Lysine 394 is a novel Rad6B-induced ubiquitination site on beta-catenin. Gerard B; Sanders MA; Visscher DW; Tait L; Shekhar MP Biochim Biophys Acta; 2012 Oct; 1823(10):1686-96. PubMed ID: 22705350 [TBL] [Abstract][Full Text] [Related]
7. Essential role of T-cell factor/beta-catenin in regulation of Rad6B: a potential mechanism for Rad6B overexpression in breast cancer cells. Shekhar MP; Tait L; Gerard B Mol Cancer Res; 2006 Oct; 4(10):729-45. PubMed ID: 17050667 [TBL] [Abstract][Full Text] [Related]
8. 1-Benzyl-indole-3-carbinol is a highly potent new small molecule inhibitor of Wnt/β-catenin signaling in melanoma cells that coordinately inhibits cell proliferation and disrupts expression of microphthalmia-associated transcription factor isoform-M. Kundu A; Khouri MG; Aryana S; Firestone GL Carcinogenesis; 2017 Dec; 38(12):1207-1217. PubMed ID: 29028954 [TBL] [Abstract][Full Text] [Related]
16. Rad6 is a Potential Early Marker of Melanoma Development. Rosner K; Adsule S; Haynes B; Kirou E; Kato I; Mehregan DR; Shekhar MP Transl Oncol; 2014 May; 7(3):384-92. PubMed ID: 24831578 [TBL] [Abstract][Full Text] [Related]
17. Wnt/β-catenin signaling inhibitor ICG-001 enhances pigmentation of cultured melanoma cells. Kim KI; Jeong DS; Jung EC; Lee JH; Kim CD; Yoon TJ J Dermatol Sci; 2016 Nov; 84(2):160-168. PubMed ID: 27567978 [TBL] [Abstract][Full Text] [Related]
18. The WNT/Beta-catenin pathway in melanoma. Larue L; Delmas V Front Biosci; 2006 Jan; 11():733-42. PubMed ID: 16146765 [TBL] [Abstract][Full Text] [Related]
19. Role of miR-214 in regulation of β-catenin and the malignant phenotype of melanoma. Prabhakar K; Rodrίguez CI; Jayanthy AS; Mikheil DM; Bhasker AI; Perera RJ; Setaluri V Mol Carcinog; 2019 Nov; 58(11):1974-1984. PubMed ID: 31338875 [TBL] [Abstract][Full Text] [Related]
20. RAD6B overexpression confers chemoresistance: RAD6 expression during cell cycle and its redistribution to chromatin during DNA damage-induced response. Lyakhovich A; Shekhar MP Oncogene; 2004 Apr; 23(17):3097-106. PubMed ID: 14981545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]